Cargando…
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease
BACKGROUND: Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer’s disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-inva...
Autores principales: | Siedlecki-Wullich, Dolores, Català-Solsona, Judit, Fábregas, Cristina, Hernández, Isabel, Clarimon, Jordi, Lleó, Alberto, Boada, Merce, Saura, Carlos A., Rodríguez-Álvarez, José, Miñano-Molina, Alfredo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521366/ https://www.ncbi.nlm.nih.gov/pubmed/31092279 http://dx.doi.org/10.1186/s13195-019-0501-4 |
Ejemplares similares
-
microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
por: Siedlecki-Wullich, Dolores, et al.
Publicado: (2021) -
Proteasomal-Mediated Degradation of AKAP150 Accompanies AMPAR Endocytosis during cLTD
por: Cheng, Wenwen, et al.
Publicado: (2020) -
Nr4a2 Transcription Factor in Hippocampal Synaptic Plasticity, Memory and Cognitive Dysfunction: A Perspective Review
por: Català-Solsona, Judit, et al.
Publicado: (2021) -
YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
por: Querol-Vilaseca, Marta, et al.
Publicado: (2017) -
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
por: Querol-Vilaseca, Marta, et al.
Publicado: (2019)